ID   BAIP2_RAT               Reviewed;         535 AA.
AC   Q6GMN2; Q923H3;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   02-OCT-2024, entry version 164.
DE   RecName: Full=BAR/IMD domain-containing adapter protein 2 {ECO:0000250|UniProtKB:Q9UQB8};
DE   AltName: Full=Brain-specific angiogenesis inhibitor 1-associated protein 2;
DE            Short=BAI-associated protein 2;
DE            Short=BAI1-associated protein 2;
DE   AltName: Full=Insulin receptor substrate protein of 53 kDa;
DE            Short=IRSp53;
DE            Short=Insulin receptor substrate p53;
DE   AltName: Full=Insulin receptor tyrosine kinase substrate protein p53;
GN   Name=Baiap2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11514062; DOI=10.1016/s0304-3940(01)02064-x;
RA   Thomas E.A., Foye P.E., Alvarez C.E., Usui H., Sutcliffe J.G.;
RT   "Insulin receptor substrate protein p53 localization in rats suggests
RT   mechanism for specific polyglutamine neurodegeneration.";
RL   Neurosci. Lett. 309:145-148(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 12-18 AND 41-50, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [4]
RP   PHOSPHORYLATION, MUTAGENESIS OF TYR-17; TYR-115 AND TYR-178, ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=11741283; DOI=10.1006/bbrc.2001.6102;
RA   Okamura-Oho Y., Miyashita T., Yamada M.;
RT   "Distinctive tissue distribution and phosphorylation of IRSp53 isoforms.";
RL   Biochem. Biophys. Res. Commun. 289:957-960(2001).
RN   [5]
RP   INTERACTION WITH TIAM1.
RX   PubMed=15899863; DOI=10.1128/mcb.25.11.4602-4614.2005;
RA   Connolly B.A., Rice J., Feig L.A., Buchsbaum R.J.;
RT   "Tiam1-IRSp53 complex formation directs specificity of rac-mediated actin
RT   cytoskeleton regulation.";
RL   Mol. Cell. Biol. 25:4602-4614(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; SER-367 AND SER-455, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Adapter protein that links membrane-bound small G-proteins to
CC       cytoplasmic effector proteins. Necessary for CDC42-mediated
CC       reorganization of the actin cytoskeleton and for RAC1-mediated membrane
CC       ruffling. Involved in the regulation of the actin cytoskeleton by WASF
CC       family members and the Arp2/3 complex. Plays a role in neurite growth.
CC       Acts syngeristically with ENAH to promote filipodia formation. Plays a
CC       role in the reorganization of the actin cytoskeleton in response to
CC       bacterial infection. Participates in actin bundling when associated
CC       with EPS8, promoting filopodial protrusions (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Interacts with CDC42 and RAC1 that have been
CC       activated by GTP binding. Binds TIAM1. Interacts with ATN1, ADGRB1,
CC       DIAPH1, EPS8, SHANK1, SHANK2, SHANK3, WASF1 and WASF2. Interacts with
CC       ENAH after recruitment of CDC42 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q6GMN2; Q9Z252: Lin7b; NbExp=3; IntAct=EBI-6997402, EBI-7001699;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Cell projection, filopodium
CC       {ECO:0000250}. Cell projection, ruffle {ECO:0000250}. Cytoplasm,
CC       cytoskeleton {ECO:0000250}. Note=Detected throughout the cytoplasm in
CC       the absence of specific binding partners. Detected in filopodia and
CC       close to membrane ruffles. Recruited to actin pedestals that are formed
CC       upon infection by bacteria at bacterial attachment sites (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=IRS-58;
CC         IsoId=Q6GMN2-1; Sequence=Displayed;
CC       Name=2; Synonyms=IRSp53S, BAIAP2-alpha;
CC         IsoId=Q6GMN2-2; Sequence=VSP_015510;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11514062,
CC       ECO:0000269|PubMed:11741283}.
CC   -!- DOMAIN: The IMD domain forms a coiled coil. The isolated domain can
CC       induce actin bundling and filopodia formation. In the absence of G-
CC       proteins intramolecular interaction between the IMD and the SH3 domain
CC       gives rise to an auto-inhibited state of the protein. Interaction of
CC       the IMD with RAC1 or CDC42 leads to activation (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The SH3 domain interacts with ATN1, ADGRB1, WASF1, WASF2,
CC       SHANK1, DIAPH1 and ENAH. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine residues by INSR in response to insulin
CC       treatment. {ECO:0000269|PubMed:11741283}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY037934; AAK72488.1; -; mRNA.
DR   EMBL; BC074009; AAH74009.1; -; mRNA.
DR   RefSeq; NP_476544.1; NM_057196.1. [Q6GMN2-2]
DR   RefSeq; XP_006247931.1; XM_006247869.3. [Q6GMN2-1]
DR   AlphaFoldDB; Q6GMN2; -.
DR   SMR; Q6GMN2; -.
DR   BioGRID; 250757; 9.
DR   CORUM; Q6GMN2; -.
DR   IntAct; Q6GMN2; 10.
DR   MINT; Q6GMN2; -.
DR   STRING; 10116.ENSRNOP00000005687; -.
DR   iPTMnet; Q6GMN2; -.
DR   PhosphoSitePlus; Q6GMN2; -.
DR   jPOST; Q6GMN2; -.
DR   PaxDb; 10116-ENSRNOP00000005687; -.
DR   ABCD; Q6GMN2; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000005687.7; ENSRNOP00000005687.6; ENSRNOG00000004049.8. [Q6GMN2-1]
DR   Ensembl; ENSRNOT00000068437.5; ENSRNOP00000060172.3; ENSRNOG00000004049.8. [Q6GMN2-2]
DR   Ensembl; ENSRNOT00055055913; ENSRNOP00055046070; ENSRNOG00055032377. [Q6GMN2-1]
DR   Ensembl; ENSRNOT00060052126; ENSRNOP00060043351; ENSRNOG00060029965. [Q6GMN2-1]
DR   Ensembl; ENSRNOT00065005955; ENSRNOP00065004272; ENSRNOG00065004025. [Q6GMN2-1]
DR   GeneID; 117542; -.
DR   KEGG; rno:117542; -.
DR   AGR; RGD:619814; -.
DR   CTD; 10458; -.
DR   RGD; 619814; Baiap2.
DR   eggNOG; ENOG502QUM6; Eukaryota.
DR   GeneTree; ENSGT00940000153560; -.
DR   HOGENOM; CLU_025877_0_1_1; -.
DR   InParanoid; Q6GMN2; -.
DR   OMA; KNSYATX; -.
DR   OrthoDB; 3059844at2759; -.
DR   PhylomeDB; Q6GMN2; -.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   PRO; PR:Q6GMN2; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000004049; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0061846; C:dendritic spine cytoplasm; IDA:RGD.
DR   GO; GO:0060076; C:excitatory synapse; IDA:RGD.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030027; C:lamellipodium; IDA:ARUK-UCL.
DR   GO; GO:0005874; C:microtubule; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0061845; C:neuron projection branch point; IDA:RGD.
DR   GO; GO:0044306; C:neuron projection terminus; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0098794; C:postsynapse; IDA:RGD.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:RGD.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0008093; F:cytoskeletal anchor activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:RGD.
DR   GO; GO:0070064; F:proline-rich region binding; ISS:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:RGD.
DR   GO; GO:0001221; F:transcription coregulator binding; IPI:RGD.
DR   GO; GO:0051764; P:actin crosslink formation; ISS:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEP:RGD.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IEP:RGD.
DR   GO; GO:0016358; P:dendrite development; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0007009; P:plasma membrane organization; IEA:InterPro.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IBA:GO_Central.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IMP:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:0035418; P:protein localization to synapse; IMP:RGD.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:1905274; P:regulation of modification of postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   CDD; cd07646; I-BAR_IMD_IRSp53; 1.
DR   CDD; cd11915; SH3_Irsp53; 1.
DR   Gene3D; 1.20.1270.60; Arfaptin homology (AH) domain/BAR domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR030128; BAIP2_I-BAR_dom.
DR   InterPro; IPR035594; BAIP2_SH3.
DR   InterPro; IPR013606; I-BAR_dom.
DR   InterPro; IPR027681; IRSp53/IRTKS/Pinkbar.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR14206; BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1-ASSOCIATED PROTEIN 2; 1.
DR   PANTHER; PTHR14206:SF3; BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1-ASSOCIATED PROTEIN 2; 1.
DR   Pfam; PF08397; IMD; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; BAR/IMD domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS51338; IMD; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Membrane; Phosphoprotein;
KW   Reference proteome; SH3 domain.
FT   CHAIN           1..535
FT                   /note="BAR/IMD domain-containing adapter protein 2"
FT                   /id="PRO_0000064818"
FT   DOMAIN          1..250
FT                   /note="IMD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00668"
FT   DOMAIN          375..438
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          308..370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          445..486
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1..251
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        323..368
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        445..460
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQB8"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQB8"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQB8"
FT   MOD_RES         341
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQB8"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQB8"
FT   MOD_RES         361
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQB8"
FT   MOD_RES         367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQB8"
FT   MOD_RES         396
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BKX1"
FT   MOD_RES         455
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         513..535
FT                   /note="RNPFANVHLKPTVTNDRSAPLLS -> SGSGTLVSTV (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:11514062"
FT                   /id="VSP_015510"
FT   MUTAGEN         17
FT                   /note="Y->F: Loss of phosphorylation; when associated with
FT                   F-115 and F-178."
FT                   /evidence="ECO:0000269|PubMed:11741283"
FT   MUTAGEN         115
FT                   /note="Y->F: Loss of phosphorylation; when associated with
FT                   F-17 and F-178."
FT                   /evidence="ECO:0000269|PubMed:11741283"
FT   MUTAGEN         178
FT                   /note="Y->F: Loss of phosphorylation; when associated with
FT                   F-17 and F-115."
FT                   /evidence="ECO:0000269|PubMed:11741283"
SQ   SEQUENCE   535 AA;  59183 MW;  606CED16E5DFD212 CRC64;
     MSLSRSEEMH RLTENVYKTI MEQFNPSLRN FIAMGKNYEK ALAGVTFAAK GYFDALVKMG
     ELASESQGSK ELGDVLFQMA EVHRQIQNQL EEMLKAFHNE LLTQLEQKVE LDSRYLSAAL
     KKYQTEQRSK GDALDKCQAE LKKLRKKSQG SKNPQKYSDK ELQYIDAISN KQGELENYVS
     DGYKTALTEE RRRFCFLVEK QCAVAKNSAA YHSKGKELLA QKLPLWQQAC ADPNKIPDRA
     AQLMQQMANS NGSILPSALS ASKSNLVISD PIPGAKPLPV PPELAPFVGR MSAQENVPVM
     NGVAGADSED YNPWADRKAA QPKSLSPPQS QSKLSDSYSN TLPVRKSVTP KNSYATTENK
     TLPRSSSMAA GLERNGRMRV KAIFSHAAGD NSTLLSFKEG DLITLLVPEA RDGWHYGESE
     KTKMRGWFPF SYTRVLDSDG SDRLHMSLQQ GKSSSTGNLL DKDDLALPPP DYGTSSRAFP
     SQTAGTFKQR PYSVAVPAFS QGLDDYGARS VSRNPFANVH LKPTVTNDRS APLLS
//
